Pierre-Emmanuel Rautou Selected Research

Neoplasms (Cancer)

1/2019	Comparison of endothelial promoter efficiency and specificity in mice reveals a subset of Pdgfb-positive hematopoietic cells.
1/2017	Long-term Outcome and Analysis of Dysfunction of Transjugular Intrahepatic Portosystemic Shunt Placement in Chronic Primary Budd-Chiari Syndrome.
2/2013	Microvesicles as risk markers for venous thrombosis.
1/2012	Management of hepatic vascular diseases.
11/2011	Predictors of tumor response after preoperative chemoradiotherapy for rectal adenocarcinomas.
12/2010	Autophagy in liver diseases.
7/2009	Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre-Emmanuel Rautou Research Topics

Disease

37	Fibrosis (Cirrhosis) 06/2024 - 01/2012
15	Portal Hypertension 06/2024 - 01/2011
13	Liver Diseases (Liver Disease) 11/2023 - 06/2014
12	Ascites 06/2024 - 09/2010
10	Hemorrhage 06/2024 - 07/2009
10	Inflammation (Inflammations) 11/2022 - 08/2011
8	Thrombosis (Thrombus) 01/2022 - 01/2012
7	Budd-Chiari Syndrome (Budd Chiari Syndrome) 06/2020 - 11/2009
7	Neoplasms (Cancer) 01/2019 - 07/2009
5	End Stage Liver Disease 10/2023 - 05/2009
5	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2010
4	Liver Cirrhosis (Hepatic Cirrhosis) 08/2023 - 06/2015
4	Infections 01/2022 - 01/2018
4	Alcoholic Hepatitis 01/2017 - 09/2014
3	Non-alcoholic Fatty Liver Disease 12/2023 - 01/2019
3	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 11/2022 - 09/2015
3	Varicose Veins (Varicose Vein) 12/2021 - 10/2011
3	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 08/2021 - 01/2017
3	Hepatitis B 12/2020 - 09/2006
3	Necrosis 01/2014 - 09/2008
3	Atherosclerotic Plaque (Atheroma) 02/2011 - 10/2008
2	Sepsis (Septicemia) 06/2024 - 01/2018
2	Brain Diseases (Brain Disorder) 06/2024 - 01/2023
2	Fatty Liver 05/2024 - 10/2023
2	Type 2 Diabetes Mellitus (MODY) 12/2023 - 01/2022
2	Bacterial Infections (Bacterial Infection) 08/2023 - 09/2015
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023 - 02/2013
2	Cholestasis 10/2021 - 05/2007
2	Starvation 01/2020 - 01/2014
2	Anorexia Nervosa 01/2020 - 09/2008
2	Idiopathic Noncirrhotic Portal Hypertension 01/2019 - 01/2016
2	Hypoxia (Hypoxemia) 01/2016 - 11/2011
2	Hepatic Encephalopathy 01/2016 - 02/2015
2	Esophageal and Gastric Varices (Esophageal Varices) 02/2015 - 01/2011
2	Coinfection 09/2014 - 09/2006
2	Hyponatremia 08/2012 - 09/2010
2	Adenocarcinoma 11/2011 - 05/2007
1	Thrombocytopenia (Thrombopenia) 06/2024
1	Acute-On-Chronic Liver Failure 06/2024
1	Craniocerebral Trauma (Head Injury) 01/2023
1	Rare Diseases (Rare Disease) 01/2023
1	Hyperbilirubinemia 01/2023
1	Hematoma 12/2022
1	Aortic Dissection 11/2022
1	Rupture 11/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Liver Failure 01/2022
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2022

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 04/2024 - 08/2011
5	4-(3-chlorophenylsulfanyl)piperidineIBA 01/2023 - 12/2018
5	CreatinineIBA 01/2023 - 05/2010
4	Prothrombin (Factor II)IBA 01/2022 - 09/2008
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2009
4	CytokinesIBA 09/2014 - 10/2008
3	RNA (Ribonucleic Acid)IBA 11/2022 - 09/2006
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2014
3	SodiumIBA 12/2021 - 08/2012
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2021 - 02/2011
2	Fibrinogen (Factor I)FDA Link 06/2024 - 03/2024
2	Hemoglobins (Hemoglobin)IBA 06/2024 - 12/2022
2	C-Reactive ProteinIBA 05/2024 - 08/2023
2	Keratin-18 (Keratin 18)IBA 10/2023 - 07/2012
2	MicroRNAs (MicroRNA)IBA 08/2023 - 01/2014
2	BilirubinIBA 01/2023 - 02/2015
2	Interleukin-6 (Interleukin 6)IBA 12/2021 - 01/2020
2	DiureticsIBA 12/2021 - 08/2012
2	SteroidsIBA 11/2021 - 01/2017
2	von Willebrand FactorIBA 08/2021 - 03/2015
2	Beclin-1IBA 01/2020 - 12/2010
2	CalreticulinIBA 11/2017 - 01/2017
2	InterferonsIBA 01/2017 - 09/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2015 - 07/2009
2	Alanine Transaminase (SGPT)IBA 11/2009 - 09/2008
1	Protons (Proton)IBA 12/2023
1	Transaminases (Aminotransferases)IBA 11/2023
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2023
1	EsterasesIBA 01/2023
1	Choline (Choline Chloride)IBA 01/2023
1	Hemostatics (Antihemorrhagics)IBA 01/2023
1	ruxolitinibIBA 11/2022
1	Syntex adjuvant formulationIBA 03/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	LigandsIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	eculizumab FDA Link 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	insulin receptor-related receptor (IRR)IBA 01/2022

Therapy/Procedure

18	Therapeutics 01/2023 - 09/2006
11	Liver Transplantation 06/2024 - 01/2012
7	Surgical Portasystemic Shunt (Portosystemic Shunt) 04/2023 - 05/2009
5	Transjugular Intrahepatic Portasystemic Shunt 08/2022 - 05/2009
3	Hematopoietic Stem Cell Transplantation 11/2022 - 09/2015
3	Stents 07/2022 - 01/2016
3	Transplantation 01/2020 - 06/2014
3	Ligation 05/2018 - 10/2008
2	Drug Therapy (Chemotherapy) 01/2019 - 09/2015
1	Cholecystectomy 04/2024
1	Hepatectomy 10/2023